Journal profile · Biochemistry, Genetics and Molecular Biology-General Biochemistry,Genetics and Molecular Biology
Current Research in Translational Medicine
ISSN 2452-3186 · Elsevier Masson · France
Current Research in Translational Medicine: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.02; hybrid open access; APC about USD 3,700; median 119 days to acceptance (102 articles, last 24 months); 69 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Current Research in Translational Medicine is published by Elsevier Masson and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Acute Myeloid Leukemia Research, CAR-T cell therapy research and Hematopoietic Stem Cell Transplantation, together about 26.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Formely Pathologie & BiologieCurrent Research in Translational Medicine is a peer-reviewed e-only journal, publishing worldwide clinical and basic research in the field of hematology, immunology, hematopoietic cell transplantation, cellular and gene therapy.The journal considers for publication editorials, original articles, state-of-the-art articles, reviews, short reports, clinical images, and letters to the editors.Contributions are intended to draw attention to experimental medicine and translational research. Current Research in Translational Medicine publishes topical special issues and is indexed in all major international databases (2023 Impact Factor: 3.2. Source: 2023 Journal Citation Reports, Clarivate Analytics).Topics covered in Current Research in Translational Medicine are:HematologyImmunologyHematopoietic Cell TransplantationCellular and Gene TherapyRNA biology (vaccines and related research)Artificial Intelligence in Medicine and Bioinformatics4 issues per year
From the journal's Aims & Scope
Research area (LetPub): Biochemistry, Genetics and Molecular Biology-General Biochemistry,Genetics and Molecular Biology
Editorial board by country: 2 in mainland China (about 6%); most named France 12, United States 5, Germany 5, Mainland China 2, United Kingdom 2 (34 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Acute Myeloid Leukemia ResearchMedicine9.2%
- CAR-T cell therapy researchMedicine8.8%
- Hematopoietic Stem Cell TransplantationMedicine8.1%
- Human auditory perception and evaluationEngineering8.1%
- Educational Robotics and EngineeringComputer Science8.1%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance7.5%
- Mesenchymal stem cell researchMedicine5%
- Lymphoma Diagnosis and TreatmentMedicine4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
2023 Journal Citation Reports, Clarivate AnalyticsPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.02LetPub ·
- Impact factor (publisher) 2023
- 3.2Publisher website ·
- CiteScore 2026-06
- 5.5LetPub ·
- CiteScore (publisher)
- 5.5Publisher website ·
- SJR 2026-06
- 0.88LetPub ·
- SNIP 2026-06
- 0.83LetPub ·
- h-index
- 54LetPub ·
- h-index
- 34OpenAlex ·
- i10-index
- 137OpenAlex ·
- 2-year mean citedness
- 1.87OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 22.52%LetPub ·
Volume
- Articles per year
- 48LetPub ·
Articles by year OpenAlex count · 484 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 45 | 11 | 5 |
| 2025 | 69 | 21 | 160 |
| 2024 | 44 | 13 | 130 |
| 2023 | 55 | 13 | 270 |
| 2022 | 42 | 13 | 385 |
| 2021 | 48 | 18 | 478 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
119 daysMedian, submission to acceptance · P25–P75 65 days – 183 days
- Acceptance to online
- median 1 days (102 articles)
- Submission to online
- median 120 days
- Sample
- 102 articles with submission and acceptance dates (119 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 4 daysPublisher website ·
- First decision after review
- 42 daysPublisher website ·
- Submission to acceptance
- 117 daysPublisher website ·
- Acceptance to publication
- 1 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,700 / EUR 3,370 / GBP 2,960 / JPY 458,910 | — | — | |
| Publisher website | USD 4,070 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Manuscript length
- ≤ 4,000 words
- Reference style
- Numbered, in order of citation
- Highlights
- Required
- Graphical abstract
- Optional
Article types accepted12, with length limits
- brief communicationEditorialEditorials focus on expressing an opinion on a specific subject in the field that currently may be up for debate. Editorials are limited 1,000 words an…main text ≤ 2,500 words
- case reportEditorialEditorials focus on expressing an opinion on a specific subject in the field that currently may be up for debate. Editorials are limited 1,000 words an…Length not stated
- clinical imageThe Clinical image generally concentrates on visual discovery, impression, and knowledge. It is not intended to be a case report and should not replace a letter…Length not stated
- commentaryEditorialEditorials focus on expressing an opinion on a specific subject in the field that currently may be up for debate. Editorials are limited 1,000 words an…Length not stated
- editorialEditorialEditorials focus on expressing an opinion on a specific subject in the field that currently may be up for debate. Editorials are limited 1,000 words an…main text ≤ 1,000 words
- general reviewGeneral review articles may either be submitted on invitation by the Editors or by spontaneous submission from authors. This type of article aims at developing …Length not stated
- letterEditorialEditorials focus on expressing an opinion on a specific subject in the field that currently may be up for debate. Editorials are limited 1,000 words an…Length not stated
- letter to the editorEditorialEditorials focus on expressing an opinion on a specific subject in the field that currently may be up for debate. Editorials are limited 1,000 words an…main text ≤ 1,500 words
- opinionEditorialEditorials focus on expressing an opinion on a specific subject in the field that currently may be up for debate. Editorials are limited 1,000 words an…Length not stated
- original articleEditorialEditorials focus on expressing an opinion on a specific subject in the field that currently may be up for debate. Editorials are limited 1,000 words an…Length not stated
- reviewEditorialEditorials focus on expressing an opinion on a specific subject in the field that currently may be up for debate. Editorials are limited 1,000 words an…main text ≤ 5,000 words
- review articleEditorialEditorials focus on expressing an opinion on a specific subject in the field that currently may be up for debate. Editorials are limited 1,000 words an…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Masson
- Country or region
- France
- Language
- English
- ISSN
- 2452-3186
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Current Research in Translational Medicine
What CAS zone is Current Research in Translational Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Research in Translational Medicine is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current Research in Translational Medicine?
The latest impact factor listed by LetPub is 3.02; CiteScore 5.5, h-index 34.
How long does peer review take at Current Research in Translational Medicine?
Based on the dates recorded on 102 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 119 days (interquartile range 65–183 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Current Research in Translational Medicine?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Manuscript length: ≤ 4,000 words; Reference style: Numbered, in order of citation; Highlights: Required; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Current Research in Translational Medicine based?
Of the 34 board members whose country the journal's board page names, 2 (about 6%) are in mainland China; the countries named most often are France (12), United States (5) and Germany (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Current Research in Translational Medicine?
According to LetPub and DOAJ records, Current Research in Translational Medicine is indexed in SCIE and Scopus.
Is Current Research in Translational Medicine open access, and what is the APC?
Current Research in Translational Medicine is a hybrid journal. For open-access publication: APC about USD 3,700.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .